ES2020171T3 - Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos. - Google Patents

Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.

Info

Publication number
ES2020171T3
ES2020171T3 ES90200167T ES90200167T ES2020171T3 ES 2020171 T3 ES2020171 T3 ES 2020171T3 ES 90200167 T ES90200167 T ES 90200167T ES 90200167 T ES90200167 T ES 90200167T ES 2020171 T3 ES2020171 T3 ES 2020171T3
Authority
ES
Spain
Prior art keywords
hydroxiacides
hydroxymethylindazole
ethers
benzyl
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90200167T
Other languages
English (en)
Other versions
ES2020171A4 (es
Inventor
Leandro Baiocchi
Bruno Silvestrini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Publication of ES2020171A4 publication Critical patent/ES2020171A4/es
Application granted granted Critical
Publication of ES2020171T3 publication Critical patent/ES2020171T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

COMPUESTO DE LA FORMULA EN DONDE A,R,R'' Y R"'' TIENEN LOS SIGNIFICADOS MENCIONADOS EN LA DESCRIPCION, SALES DE EL CON BASES FARMACEUTICAMENTE ACEPTABLES, PRODUCTOS INTERMEDIOS Y PROCESOS PARA SU PREPARACION, Y COMPOSICIONES FARMACEUTICAS CONTENIENDOLO.
ES90200167T 1989-02-07 1990-01-23 Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos. Expired - Lifetime ES2020171T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (2)

Publication Number Publication Date
ES2020171A4 ES2020171A4 (es) 1991-08-01
ES2020171T3 true ES2020171T3 (es) 1995-12-01

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90200167T Expired - Lifetime ES2020171T3 (es) 1989-02-07 1990-01-23 Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.

Country Status (36)

Country Link
US (2) US4999367A (es)
EP (1) EP0382276B1 (es)
JP (1) JP2870925B2 (es)
KR (1) KR0145525B1 (es)
CN (2) CN1046505C (es)
AR (1) AR247386A1 (es)
AT (1) ATE127115T1 (es)
AU (1) AU624895B2 (es)
BG (1) BG50273A3 (es)
CA (1) CA2009503C (es)
CZ (1) CZ280121B6 (es)
DD (2) DD295363A5 (es)
DE (2) DE382276T1 (es)
DK (1) DK0382276T3 (es)
EG (1) EG19170A (es)
ES (1) ES2020171T3 (es)
FI (1) FI102678B (es)
GE (1) GEP19971030B (es)
GR (2) GR910300073T1 (es)
HU (1) HU204793B (es)
IL (1) IL93132A (es)
IN (1) IN170957B (es)
IT (1) IT1230441B (es)
LT (1) LT3604B (es)
LV (1) LV10612B (es)
NZ (1) NZ232258A (es)
PE (1) PE25091A1 (es)
PH (1) PH26552A (es)
PL (2) PL163720B1 (es)
PT (1) PT93067B (es)
RO (1) RO106252B1 (es)
RU (3) RU2066318C1 (es)
SK (1) SK278441B6 (es)
UA (1) UA26852C2 (es)
YU (1) YU47943B (es)
ZA (1) ZA90644B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EP2254870B1 (en) * 2008-03-07 2016-02-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
US8461194B2 (en) 2008-03-07 2013-06-11 Aziende Chimiche Riunite Angelini Francesco A. C. R. A. F. S. P. A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
US8314099B2 (en) 2008-03-07 2012-11-20 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
EP2462119B1 (en) * 2009-08-03 2014-06-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole and its derivatives and required Magnesium intermediates
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
CA3095012C (en) 2012-05-01 2023-02-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2013171316A1 (en) 2012-05-18 2013-11-21 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
SI2882715T1 (sl) 2012-05-18 2017-03-31 Sanofi Derivati pirazola in njihova uporaba kot antagonisti LPAR5
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
CA3144861A1 (en) * 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
PT93067A (pt) 1990-08-31
HU204793B (en) 1992-02-28
GR910300073T1 (en) 1991-11-15
GR3018165T3 (en) 1996-02-29
ZA90644B (en) 1991-01-30
HU900689D0 (en) 1990-04-28
IN170957B (es) 1992-06-20
EG19170A (en) 1994-11-30
EP0382276A2 (en) 1990-08-16
BG50273A3 (en) 1992-06-15
PL163720B1 (pl) 1994-04-29
JPH02240065A (ja) 1990-09-25
ATE127115T1 (de) 1995-09-15
NZ232258A (en) 1991-06-25
YU20690A (sh) 1992-07-20
CA2009503A1 (en) 1990-08-07
UA26852C2 (uk) 1999-12-29
YU47943B (sh) 1996-07-24
PL163730B1 (pl) 1994-04-29
CN1046505C (zh) 1999-11-17
IT1230441B (it) 1991-10-23
CA2009503C (en) 2000-04-11
SK56390A3 (en) 1997-05-07
CN1088201A (zh) 1994-06-22
FI900577A0 (fi) 1990-02-06
PE25091A1 (es) 1991-08-17
AR247386A1 (es) 1994-12-29
JP2870925B2 (ja) 1999-03-17
ES2020171A4 (es) 1991-08-01
HUT53088A (en) 1990-09-28
KR0145525B1 (ko) 1998-08-17
US4999367A (en) 1991-03-12
EP0382276A3 (en) 1990-12-12
IT8947620A0 (it) 1989-02-07
DE382276T1 (de) 1991-11-28
DK0382276T3 (da) 1996-01-15
SK278441B6 (en) 1997-05-07
IL93132A0 (en) 1990-11-05
AU4906690A (en) 1990-08-16
DE69021902D1 (de) 1995-10-05
DD291995A5 (de) 1991-07-18
RU2044729C1 (ru) 1995-09-27
EP0382276B1 (en) 1995-08-30
RO106252B1 (ro) 1993-03-31
LV10612A (lv) 1995-04-20
LT3604B (en) 1995-12-27
CZ280121B6 (cs) 1995-11-15
CN1034016C (zh) 1997-02-12
RU2055071C1 (ru) 1996-02-27
PT93067B (pt) 1995-12-29
LTIP872A (en) 1995-03-27
DD295363A5 (de) 1991-10-31
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
KR900012913A (ko) 1990-09-03
PH26552A (en) 1992-08-19
FI102678B (fi) 1999-01-29
AU624895B2 (en) 1992-06-25
LV10612B (en) 1995-08-20
CZ56390A3 (en) 1995-06-14
DE69021902T2 (de) 1996-05-23
US5112986A (en) 1992-05-12
RU2066318C1 (ru) 1996-09-10
IL93132A (en) 1994-05-30
CN1044810A (zh) 1990-08-22

Similar Documents

Publication Publication Date Title
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9204354A (es) Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
MX9206305A (es) Bifenilpiridonas substitutas, procedimiento para su obtencion y medicamento que los contiene.
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
AR030857A1 (es) Derivados nitroso de difenolaminas, composiciones farmaceuticas que los contienen y su uso en la preparacion de productos medicinales
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
IT8047848A0 (it) Derivati triciclici e loro sali farmacologicamente attivi e composizioni farmaceutiche che li contengono, nonche' procedimento per la loro preparazione
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
IT1240350B (it) Derivati di tieno-triazolo-diazepine,un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
IT1240935B (it) Derivati di tieno-triazolo-diazepine, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
ES2041617T3 (es) Productos intermedios para agentes de quelacion con simetria prefijada y procedimiento para su preparacion.
DK0443848T3 (da) Nyt antiulcermiddel
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
IT9019793A0 (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
ITMI912745A0 (it) Derivati 5h-benzodiazepinici, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
MX9200996A (es) Compuestos heterociclicos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
IT1129305B (it) Derivati di 1,2,4 ossadiazolin 5 one procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1218322B (it) Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
ITMI910846A1 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
LV10917A (lv) Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 382276

Country of ref document: ES